NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Rising demand for mesenchymal stem cell (MSC)-based therapies, coupled with expanding applications in regenerative medicine, immunotherapy, and tissue ...
Product-focused roadmap shows how MSC secretomes can become scalable, standardized, GMP-ready biotherapeutics.
Figure 1: Immunomodulatory effects of simulated MSCs. MSCs utilize different molecular mechanisms to suppress (in most cases) or activate immune cells. Orange arrows: inhibition; Green arrows: ...
The promise of mesenchymal stem cells (MSCs) to heal heart disease could be around the corner thanks to a new delivery method tested by regenerative medicine company Cynata Therapeutics Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results